Patients

At Ipsen, patients motivate every decision we make.

WORKING WITH PATIENTS, FOR PATIENTS

Ipsen works with patients, their families, and more than 250 patient organizations around the world at a global, regional, and national level. Our key priorities are generating data and sharing experiences. We want to guarantee that patients are truly given a seat at the table when it comes to their care and the developments that Ipsen is making. We believe this kind of close collaboration and inclusion is essential to ensure we chart the right course.  Our goal is to understand and respond to patients’ needs, helping them and their caregivers at different points throughout their experiences. At Ipsen, we believe in working together with patients, for patients.

OUR WORK WITH PATIENT ORGANIZATIONS

It all starts with listening. At Ipsen, we enter into dialogue with the patient community as early as possible when developing new medicines. Our focus is on long-term strategic engagement and partnerships with patient organizations.

Top patient stories

Browse all patient stories

29 February 2024 2 mins read

Working together to create positive change in rare diseases

Every four years, Rare Disease Day lands on the ‘rarest’ day of the year, 29th February. Due to leap years, this day is normally celebrated on 28th February, but this year means it is taking place on its intended day….

12 February 2024 2 mins read

The not-so-rare challenges of rare liver diseases

Hearing a rare liver disease diagnosis can be one of the most emotionally turbulent moments in a person’s life.1 For the parents of the estimated 1 in 50,000 – 100,000 newborns impacted by rare liver diseases, this moment is all…

02 February 2024 3 mins read

Caring for a Loved One with Metastatic Pancreatic Cancer: Nora’s Story

Nora and her husband, Hector, met 39 years ago, got married shortly after, and have been inseparable ever since. In 2021, Hector was diagnosed with metastatic pancreatic cancer, which threw their entire family into navigating a very difficult diagnosis. Nora…

31 January 2024 1 mins read

Continuously improving how we engage with patient communities 2023 Ipsen patient organization engagement satisfaction survey results  

In 2023 Ipsen launched its third global patient organization engagement survey, featuring the perspectives of 85 patient organizations (POs) globally. These findings will be used to help Ipsen deliver on what matters most to patients and caregivers. For the third…

12 December 2023 3 mins read

Uniting for patients: Ipsen’s first patient centricity week – Care 2 Know More

At Ipsen, improving patients’ lives drives us. We work together with patients, for patients. However, we know that understanding how to be more patient centric can be challenging, especially if you don’t work with patients in your day-to-day role.

29 November 2023 1 mins read

‘Get men talking’: breaking the silence around prostate cancer

Tim Batchelor, Ipsen’s Head of Global Commercial Learning & Development, candidly shares his experience of living with prostate cancer. At the age of 48, Tim was confronted with a prostate cancer diagnosis. His early detection proved pivotal, leading to successful…

28 November 2023 2 mins read

Primary Biliary Cholangitis: The Power of Patient Reported Outcomes

“The important thing with PBC is to take a holistic view of it, and think ‘What are the problems we are trying to solve? The first is the risk of progression to cirrhosis, and the other is symptoms and quality…

13 November 2023 1 mins read

The Liver Meeting 2023: Innovating for people living with rare liver diseases

Jennifer Schranz (Ipsen’s Global Head of Rare Diseases) attended The Liver Meeting from November 10-14, sharing key insights from her time onsite and explaining why scientific congresses are vital in helping advance innovation for patients. 

10 November 2023 2 mins read

Ipsen’s mission to accelerate innovation in oncology

The outputs from the European Society of Medical Oncology (ESMO) Congress this year encompassed several important new data announcements, highlighting key advances in the development of therapies for people living with cancer.  However, cancer remains a formidable global health challenge,…

31 October 2023 2 mins read

Ipsen stands together to make innovation in rare disease happen

Developing innovation for people living with rare diseases is uniquely challenging. It requires all the different pieces of the puzzle– clinical viability, economic viability and the policy environment— to come together before innovation can reach patients.

Media Image

Making clinical trials accessible and understandable

We are committed to ensuring that all our published research is freely available to everyone. To make this happen, we work closely with the patient community to provide summaries of key clinical studies sponsored by Ipsen in easy-to-understand language, so they are not just available, but accessible to all.

Media Image

Ipsen Clinical Trials

Ipsen conducts first-in-the-world clinical trials to take science forward together. Our global network of healthcare professionals helps us test new treatments and ensure their efficacy and safety by conducting clinical trials. Our aim is to create new therapies and improve upon existing ones to improve patients’ lives and health outcomes.

Media Image

Our approach to responsibility

Ipsen unites all our employees behind our global commitment to doing business responsibly through Generation Ipsen – For Positive Change. This fully integrated approach is built on four pillars: Environment, Patients, People and Governance. Generation Ipsen is designed to ensure we meet patients’ needs while working in ways that are ethical, responsible and community-minded.

Alert Icon

Request medical information / report adverse event or product complaint

To request medical information on Ipsen’s products, report an adverse event or report a complaint, please visit: www.ipsenmedicalinformation.com or email us at globalmedinfo@ipsen.com

Adverse event reactions can also be reported directly to Ipsen’s local safety team using the contact details provided in the contact us pages